And researchers are focused on single diseases, or groups of similar ones, for now. Treating rare disorders will require dealing with many different mutations, even within the same disease And although rare diseases affect 30 million americans in total, relatively few people are diagnosed with each one. Despite their name, these diseases collectively impact millions of americans, creating a healthcare system that’s equal parts expensive, frustrating, and endlessly confusing With 8% of us households reporting a rare disease diagnosis and healthcare costs hitting nearly $1 trillion, it’s clear that rarity. Rare diseases should be enjoying a moment at marty makary’s fda
The fda commissioner, along with center for biologics evaluation and research director vinay prasad, has made numerous statements throughout the year apparently supportive of easing market access for new rare disease treatments and recently unveiled a plausible mechanism pathway for ultrarare conditions The ai model is already being used by rare disease foundations and by clinicians who treat patients with rare diseases “reducing research support for rare diseases now would severely disrupt the momentum created by ai,” says zitnik, who is an associate professor of biomedical informatics in the blavatnik institute at hms.
OPEN
